In a recent issue of Nature Medicine, Nasr et al. show that the effectiveness of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia is independent of their ability to cause differentiation. Targeted destruction of the PML-RARα oncoprotein appears key to eliminating the cells from which relapse can arise
Cells from patients with t(15;17) acute promyelocytic leukemia (APL) express a fusion protein betwee...
Acute promyelocytic leukemia (APL) caused by the malignant proliferation of bone marrow-derived cell...
Acute promyelocytic leukemia (APL) is a subtype of acute leukemia characterized by a unique t(15;17)...
In a recent issue of Nature Medicine, Nasr et al. show that the effectiveness of all-trans retinoic ...
Acute promyelocytic leukemia (APL) is a hematological malignancy driven by a chimeric oncoprotein co...
Acute promyelocytic leukemia (APL) is driven by the PML/RARA fusion protein, which in-terferes with ...
International audienceRetinoic acid and arsenic trioxide target the protein stability and transcript...
International audienceRetinoic acid and arsenic trioxide target the protein stability and transcript...
Incorporation of all-trans-retinoic acid (ATRA) into the treatment of acute promyelocytic leukemia (...
International audienceRetinoic acid and arsenic trioxide target the protein stability and transcript...
International audienceRetinoic acid and arsenic trioxide target the protein stability and transcript...
International audienceRetinoic acid and arsenic trioxide target the protein stability and transcript...
The recent finding that almost all patients with acute promyelocytic leukaemia (APL) may be cured us...
The recent finding that almost all patients with acute promyelocytic leukaemia (APL) may be cured us...
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia. It is characteri...
Cells from patients with t(15;17) acute promyelocytic leukemia (APL) express a fusion protein betwee...
Acute promyelocytic leukemia (APL) caused by the malignant proliferation of bone marrow-derived cell...
Acute promyelocytic leukemia (APL) is a subtype of acute leukemia characterized by a unique t(15;17)...
In a recent issue of Nature Medicine, Nasr et al. show that the effectiveness of all-trans retinoic ...
Acute promyelocytic leukemia (APL) is a hematological malignancy driven by a chimeric oncoprotein co...
Acute promyelocytic leukemia (APL) is driven by the PML/RARA fusion protein, which in-terferes with ...
International audienceRetinoic acid and arsenic trioxide target the protein stability and transcript...
International audienceRetinoic acid and arsenic trioxide target the protein stability and transcript...
Incorporation of all-trans-retinoic acid (ATRA) into the treatment of acute promyelocytic leukemia (...
International audienceRetinoic acid and arsenic trioxide target the protein stability and transcript...
International audienceRetinoic acid and arsenic trioxide target the protein stability and transcript...
International audienceRetinoic acid and arsenic trioxide target the protein stability and transcript...
The recent finding that almost all patients with acute promyelocytic leukaemia (APL) may be cured us...
The recent finding that almost all patients with acute promyelocytic leukaemia (APL) may be cured us...
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia. It is characteri...
Cells from patients with t(15;17) acute promyelocytic leukemia (APL) express a fusion protein betwee...
Acute promyelocytic leukemia (APL) caused by the malignant proliferation of bone marrow-derived cell...
Acute promyelocytic leukemia (APL) is a subtype of acute leukemia characterized by a unique t(15;17)...
DOI
Add to ORKG